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ROLE  OF  IgD IN  THE  IMMUNE  RESPONSE  AND  TOLERANCE 
I. Anti~  Pretreatment Facilitates Tolerance Induction in Adult B 
Cells In Vitro* 
BY DAVID W.  SCOTr,$  JUDITH  E.  LAYTON,  AND G.  J.  V.  NOSSAL 
(From the Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne  Hospital, 
Parkville, Victoria  3050, Australia) 
Adult murine B cells, in contrast to neonatal B cells, are relatively resistant 
to in vitro tolerance induction (1-6).  It has been suggested that the maturation 
of B  cells from bearing only IgM receptors (~-only cells) to those expressing 
beth IgM and IgD receptors (/~  +  8-cells) coincides with the development of 
resistance to in vitro tolerance induction (6-8).  Early studies, however, sug- 
gested that the loss of tolerance susceptibility in the neonatal period occurred 
before IgD was detectable on most B cells (1). More recently, this question has 
been reexamined. Cambier et al.  (8) reported that enzymatic digestion of IgD, 
for example, from the surface of murine B cells facilitated tolerance induction 
in adult T-dependent B cells. A more direct way of determining the role of IgD 
is by attempting to induce tolerance in vitro by pretreatment of adult B cells 
with an anti~  serum before culture with tolerogen. In this paper, we report 
the results of the latter and other approaches. Our results suggest that #  + 8- 
cells do become susceptible to tolerance induction if the 8-receptor is blocked or 
modulated, and that mice suppressed for the 8-allotype remained susceptible to 
tolerance in vitro into adult life. We also suggest that adult/~-only cells are 
normally rendered tolerant in vitro but their unresponsiveness can be masked 
by the response of nontolerant ~  + 8-cells. 
Materials and Methods 
Mice.  C57BL/6 and its allotype-congenic partner strain (9), C57BL/6.Ig  ~ N14F4 (abbreviated 
"Ig  ~'), were bred and maintained at the Walter and Eliza Hall Institute. Mice of either sex were 
used at various ages as described. Within an experiment, mice were of the same sex. 
Antisera.  "Anti~" serum was made in C57BL/6 mice against CBA/CaH WEHI spleen cells as 
described by  Goding et  al.  (9).  The  antisera used  contained antibodies against H-2  k  and la  ~ 
antigens as well asto the IgD-like allotypic specificity (Ig 5-1).  When tested against the C57BL/ 
6.Ig  ~ spleen cells,  only antibodies to the IgD allotype are detected  (9).  This serum is therefore 
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referred to as "antiH." Anti-~ was a  rabbit antiserum  (no. 647)  against mouse ~ochains, which 
had been previously absorbed with mouse IgG-Sepharose 4B and mouse thymocytes.  The latter 
serum was the generous gift of Dr. James Goding, of this Institute. 
Antigens.  Human gamma globulin (HGG) 1 (Cohn fraction II, Commonwealth Serum Labora- 
teries,  Melbourne,  Victoria,  Australia)  was conjugated  with  fluorescein isethiocyanate  (BBL, 
Baltimore, Md.) at a hapten: protein ratio of 1:50 in pH 9.2 carbonate-bicarbonate buffer (10, 11). 
After 2 h  at room temperature,  the conjugated protein was separated from unreacted hapten by 
passage  over  a  Biogel P-6  column  (Bio-Rad  Laboratories,  Richmond,  Calif.)  and  subsequent 
dialysis. The conjugates used had a  final fiuoresoein: protein molar ratio of 6  (FLUeHGG). For 
use as tolerogen, FLU6HGG was deaggregated at 100,000 g  for 60 rain, passed through a 0.45  ~m 
Millipore filter (Millipore Corp.,  Bedford,  Mass.),  and  stored  at  4°C  for use  within  2  wk.  As 
immunogen, Salmonella adelaide polymerized flagellin SW1338  (POL) was similarly conjugated 
with FLU before dialysis and centrifugation at 26,000  rpm  in a  Spinco 50.1  rotor to pellet the 
FLU-POL. This antigen contained an average of i FLU group/38,000 tool wt monomeric flagellin 
subunit. 
Basic Protocol 
FIRST STAG~-.  Spleen cells from C57BL/6 and C57BL.Ig  e mice were cultured at 37°C in 5% COs 
in microculture medium (MCM; reference 12) at a concentration of 5  ×  106/2 ml MCM in Linbro 
FB-TC-24 trays (Linbro Chemical Co., New Haven, Conn.). The cultures included FLU6HGG at 
5/~g/ml (or no antigen) with or without 100 izl of a  1:10 dilution of anti-8 serum (or anti-/~; see 
Results). When antiserum was included, it was added 30 rain before the addition of antigen. 
SSCONV ~rAas.  After 36-72  h  the  cells from each  well were  harvested  and  washed  twice 
through undiluted fetal calf serum. After washing, the spleen cells were subsequently diluted in 
thymus "fillers" (12) and dispensed  in 0.2-ml aliquots  in Linbro IS-FB-96-TC culture trays.  To 
eliminate  the  feedback  effects  which  can  occur  when  more  than  five antibody-forming  cell 
precursors are cultured in the same well (12,  13), each well usually contained 5  ×  104 cultured 
spleen cells, plus 1-2 ×  106 thymocytes and 20 ng FLU-POL. Thymocytes from syngeneic C57BL/6 
mice, Wistar,  and DA rats were used with equal success  as fillers (B.  Pike  and F.  Melchers, 
personal communication). After 3 days at 37°C, each well was assayed vs. FLU-sheep erythrocytes 
(SRBC), sensitized with FLU-F(ab')2 anti-SRBC (12),  in Cunningham chambers (14). Routinely, 
12-24  replicates were assayed. 
Limit  Dilution  Microculture Analysis.  In  some  experiments,  cells  were  cultured  at  limit 
dilution as described by Pike and Nossal (12) and Stocker (13). Poisson statistical analysis of the 
number of responding  and  nonrespending  wells was calculated as described by Lefkovits (15) 
applied to our culture system. 
AntiH-Suppressed Mice.  C57BL.Ig  ~ mice treated from birth with antiH serum ("suppressed" 
mice) or normal  adult C57BL/6 serum  (control mice) were prepared  as described in detail by 
Layton et al.2 These mice had virtually no detectable IgD  + cells in spleen or lymph nodes at the 
time of sacrifice. 
Results 
Age Restrictions on Clonal Abortion.  Previous studies in our laboratory (3) 
had established that neonatal, but not adult, spleen cells were susceptible to in 
vitro  tolerance  induction  (i.e.  "clonal  abortion";  reference 4).  Initially,  we 
sought to reproduce this system using the FLU-hapten and C57BL/6.Ig  ~ mice 
to allow studies with anti~ allotype serum (9) and to determine when neonatal 
cells "matured" to adultlike resistance to clonal abortion.  Briefly, we found 
that  Ig  e  spleen  cells  from  mice  less  than  7  days  of age  were  consistently 
1 Abbreviations  used in this paper:  DNP,  2-4-dinitrophenyl;  FLU, fluorescein; HGG,  human 
gamma globulin; MCM, microculture medium; Pc, phosphorylcholine; PFC, plaque-forming cell; 
POL, pelymerized flagellin; SRBC, sheep erythrocytes; TNP, trinitrophenyl. 
2 Layton, J. E., J. M. Teale, G. J. Johnson, D. W. Scott, and G. J. V. Nossal. 1977. The anti-8- 
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Fro.  1.  Effect of anti-8 on tolerance induction. Spleen cells, from 4-too-old C57.Ig  ~ mice, 
were cultured as described with no antigen, 5 ~g/ml FLU6HGG, anti-8, or both FLU-HGG 
and anti-8.  After 36  h,  the cells from each well were harvested, washed, and set up  in 
secondary cultures at 4  x  104 cells with 1.5  x  106 C57BL/6 thymocytes per well (0.2 ml). 
All cultures  were challenged with  100  ng/ml  FLU-POL and TNP-POL  as  a  specificity 
control. Only cultures exposed to FLU-HGG in the presence of anti-8 show tolerance. All 
groups responded equally to TNP. 
rendered hyporesponsive in vitro during a  48- to 72-h incubation with 5/~g/ml 
FLUsHGG (2  ×  10  -7 M  hapten).  Spleen cells from mice 2 wk of age or older, 
however,  were  generally  resistant  to  this  in  vitro  tolerance  process  (D.  W. 
Scott, unpublished results). 
Facilitating Effect of Anti-8 on Tolerance Induction.  To determine whether 
the 8-receptor  plays  an  important  role  in  preventing  tolerance  induction  in 
adult spleen cells, cells from 4-mo-old Ig  ~ mice were cultured with combinations 
of anti~  and FLU-HGG as described in Materials and Methods. After 36-48 h, 
cells from each group were washed and then challenged with FLU-POL. When 
adult Ig  e spleen cells were precultured with 5 #tg/ml FLU-HGG, or with anti-8 
serum, no effect on subsequent responsiveness to FLU-POL was observed (Fig. 
1). However, if both FLU-HGG and anti~  were continually present during the 
first  culture  stage,  then  "hyporesponsiveness"  of adult  Ig  ~ spleen  cells  was 
induced  (top bar).  The effect is hapten-specific because a  normal  response to 
trinitrophenyl  (TNP)-POL was observed (Fig.  1, bottom panel). 
Strain  Dependence.  C57BL.Ig  ~ mice express  the  surface IgD  allotype  de- 
tected by our anti-8 serum; C57BL/6 mice do not (9, 16, 17). As shown in Fig. 2, if 
spleen cells from C57BL/6 mice are treated with FLU-HGG plus anti-8, there is 
no effect (bottom panel);  as  in the  experiment  in  Fig.  1,  Ig  e spleen cells  are 
rendered hyporesponsive by this protocol (top panel). 
Lack  of Effect  of Anti-ft  on  Tolerance  Induction.  To  insure  that  the 
facilitation  of tolerance induction was a  specific effect due to interaction  with 
the 8-receptor, the effect of anti-~ was next tested. If anti-/z serum is substituted 
for anti~,  no facilitation  of tolerance  induction  is observed (Fig.  2,  top bars) 
with  Ig  ~ spleen  cells.  Similarly,  anti-re  plus  FLU-HGG pretreatment  has  no 1476  IgD  AND  TOLERANCE 
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FIG. 2.  Effect  of anti-~ vs. anti-8 on tolerance induction in C57.Ig  ~ and C57BL/6 mice. 
Protocol as in Fig. 1 except that 1.4 x 10  e Lewis rat thymus cells were used as fillers with 
cultured cells at 5 x 104/well. 
adverse effects on C57BL/6 spleen cells (not shown in Fig. 2 for simplicity). In 
fact,  a  slight  augmentation  of responsiveness  by  anti-~  +  FLU-HGG was 
observed in both strains. 
Effect of Brief Pretreatment  with Anti-8 on Tolerance Induction.  We next 
examined whether anti~  serum needs to be present throughout the first stage 
for tolerance to ensue. Spleen cells from 3-wk-old Ig  ~ mice were treated for 30 
min  at  0°C  with  anti~  serum,  then  washed  and  cultured for 48  h  with  or 
without the tolerogen, FLU-HGG. The cells in each group were then washed 
and  cultured at  10  x  10  + well  with  rat thymus fillers.  The data  in  Table  I 
demonstrate that brief  treatment with anti~ was sufficient to render "resistant" 
cells susceptible to in vitro tolerance induction with FLU-HGG. 
Ease  of  Tolerance  Induction  with  Spleen  Cells  from  8-Suppressed 
Mice.  Recently,  Layton et  al.  (see  above)  have  been  able  to  suppress  the 
expression of IgD-bearing lymphocytes in the lymphoid tissues of C57BL.Ig  ~ 
mice by treatment of these mice from birth with anti~  allotype serum. These 
mice have virtually no detectable IgD-bearing cells by immunofluorescence, 
are  slightly defective in  B  cell colony formation in  agar,  and  have  reduced 
numbers of precursors for the haptens FLU and 4-hydroxy-3-iodo-5-nitrophenYl 
(NIP) (see footnote 2 and below). Based on the results we have presented thus 
far, one might predict that spleen cells from these 8-suppressed mice would be 
highly susceptible to in vitro tolerance induction. As shown in Fig. 3 and Table D.  W.  SCOTT,  J.  E.  LAYTON,  AND  G.  J.  V.  NOSSAL  1477 
TxBu~ I 
Facilitation of Tolerance Induction by Pretreatment  with Anti-8 
Serum* 
Group  Anti-8  FLU-HGG  PFC/well 
1  +  +  10.5  _  3.5 
2  +  -  43.8 _+. 6.9 
3  -  +  30.8 -+ 6.8 
4  -  -  30.3 +-. 6.3 
* Spleen cells from 18-day-old C57BL.Ig  ~ mice were incubated -  anti-8 
for 30 rain at 0°C, washed, and cultured 48 h at 37°C in MCM ±  5 ~g/ 
ml  FLU6HGG  in  Linbro  trays.  Cells  from each  group  were  then 
washed and diluted to  105/well  in thymus fillers  +  FLU-POL and 
cultured for a  final 3 days at 37°C.  Mean plaque-forming cell (PFC) 
value of 12 wells. 
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FIG.  3.  Sensitivity to in vitro tolerance induction of spleen cells from anti-~-suppressed 
mice (see fn. 2). Secondary cultures were at 105/well with 1.4 x  108 C57BL/6 mouse thymus 
fillers. 
II, this is, indeed, the case. In Fig. 3 (top),  we reiterate the basic observation 
that anti-8 plus FLU-HGG causes hyporesponsiveness in l-too-old littermate 
controls. The lower panel shows that a degree of tolerance is observed with sup- 
pressed spleen cells by antigen alone. In the experiment recorded in Table II, not 
only are spleen cells from suppressed mice easily tolerized in vitro by antigen 
alone, but also the precursor frequency to FLU (determined by limit dilution 
analysis; references 12, 13, 15) is dramatically reduced. 1478  IgD  AND  TOLERANCE 
TABLE  II 
Susceptibility  of Adult  Spleen  Cells from  6-Suppressed  Mice to  In 
Vitro Tolerance Induction* 
Anti-FLU  (Precursor  Group  FLU-HGG  PFC/well  frequency)-1 
Suppressed*  +  2.2  _+  0.9  104,821 
Suppressed*  -  16.6  +_ 4.8  36,995 
Control  +  20.6  ___ 5.4  18,229 
Control  -  27.5  __ 3.7  17,013 
* Spleen cells from both groups were incubated with 5  ~g/ml of FLUeHGG or 
no antigen for 36 h  at 37°C in Linbro trays at 5  x  10e/2 ml MCM. They were 
then harvested,  washed,  and challenged in secondary microcultures  (with 
1.5  ×  106  DA  rat  thymus  fillers  per  well)  with  FLU-POL.  For  PFC 
determinations,  cells  were  recultured  at  105/well;  for  precursor  analysis, 
cells were diluted to 104/well. 
$ C57BL.Ig  e mice, treated with anti-8 allotype serum from birth, are referred 
to as "suppressed." At 1 mo of age, these mice had virtually no detectable 
IgD ÷ B  cells (see fn.  2).  Control mice were littermates of the same age, but 
were injected with normal C57BL serum. 
Discussion 
The results presented in this paper argue in favor of the hypothesis that 
surface IgD receptors are among the factors controlling the susceptibility of 
murine B cells to tolerance induction. When IgD is blocked or modulated off 
the membrane with anti~ allotype serum, adult B cells are no longer resistant 
to  our in  vitro tolerance regimen.  That  is,  they exhibit phenotypically the 
same degree of sensitivity to tolerogenesis as do spleen cells from neonatal mice. 
We have shown that this tolerance facilitation process is antigen-(hapten) 
specific,  strain-specific (occurs only in the appropriate strain expressing the 
relevant Ig5-1 allotype), and isotype-specific (occurs with anti~ but not anti- 
~).  The latter point is an important one because an anti-~ reagent failed to 
promote tolerance induction under conditions of time and temperature identical 
to those used for anti~. It is noteworthy that anti-Ig reagents have been used 
previously to block the  induction of tolerance in vitro  (18). Our results are 
consistent with the view that interaction of tolerogen with IgM receptors can 
provide a negative (tolerogenic) signal, whereas the presence of available IgD 
receptors on the cell surface prevents this from occurring. Thus, IgD may be a 
receptor, which in some, as yet unclear, manner prevents an encounter  between 
cell  and  antigen  being  tolerogenic.  In  other words,  IgD  can function as  a 
"failsafe" receptor. 
Very recently, Cambier et  al.  (8)  presented evidence consistent with our 
results in a system employing papain to cleave membrane IgD. These workers 
took  advantage  of the  finding  (19, 20)  that  IgD  seems  quite  sensitive  to 
proteolytic degradation, whereas other cell surface molecules are relatively 
resistant to proteolysis. Cambier et al. found that adult B cells, ai~r papain 
treatment,  became  susceptible  to  in  vitro  tolerogenesis in  the  presence of 
TNP17HGG (8). The extent of tolerance susceptibility seemed to correlate with 
the  relative  paucity  of IgD  on  the  surface;  furthermore, if the  cells  were D.  W.  SCOTT,  J.  E.  LAYTON,  AND  G.  J.  V.  NOSSAL  1479 
allowed to regenerate (in the absence of tolerogen) the molecules cleaved by 
papain, they again became resistant to tolerance induction. Unfortunately, as 
stated  by  Cambier  et  al.  (8), papain  may  remove  other  molecules which 
interfere with tolerance induction (and which may be  resynthesized at  the 
same rate as surface IgD). In fact, only approximately 10% of the macromole- 
cules  released  by  papain  treatment  can  be  identified  as  IgD  (R.  M.  E. 
Parkhouse,  personal  communication). Hence,  our demonstration that  anti~ 
pretreatment of adult B cells will facilitate tolerance induction provides more 
direct evidence for the role of IgD as a failsafe receptor. 
It  is  interesting  to  note  that  Cambier  et  al.  (6,  8)  found that  adult T- 
independent (T-I) B cells are hypersusceptible to tolerance induction in vitro as 
opposed to T-dependent (TD) B cells (1, 6), and that papain treatment has no 
effect on the threshold dose of tolerance required for T-I B cells. Our system 
uses haptenated POL, normally considered to be a T-I antigen, as the challenge 
immunogen. Superficially, this would seem to be at odds with the Cambier 
results mentioned above.  However,  it is useful to recall that our secondary 
culture system includes excess thymus filler cells, which could provide some T 
cell  "help,"  after  appropriate  in  vitro  activition  by  the  carrier  POL.  It  is 
noteworthy that this filler function is quite radiosensitive (B.  Pike, personal 
communication). 
Moreover, although haptenated POL can behave as a T-I antigen in stimulat- 
ing bulk cultures of spleen cells from nu/nu mice to form antihapten PFC, we 
have consistently found that the number of PFC generated in such bulk cultures 
is  considerably less  than that  from cultures of spleen cells from the  nu/+ 
littermates. This difference is not seen when each type of suspension is cultured 
at  limit  dilution with  thymus filler  cells.  These  findings could  indicate  a 
thymus-dependent component to the antihapten-POL response as measured at 
limit dilution, a conclusion supported by the finding of some IgG production by 
days 5 and 6 of the in vitro response.  3 Thus, although we do not observe in 
vitro tolerogenesis of adult spleen cells by the low concentrations of antigen 
used by Cambier et al.  (6,  8),  adult cultures in fact serving as the negative 
control for all our work on clonal abortion (3, 4), the differences in the readout 
system are sufficient to ensure that,  at present, no conflict of data exists. A 
further important difference in experimental design is that our tolerogens have 
always been oligovalent, carrying three to six haptens per molecule of carrier, 
whereas Cambier et al.  used TNPI~HGG (2,  6,  8).  In our experience, heavily 
haptenated proteins tend to aggregate spontaneously. Their effects in tissue 
culture might then mimic those of agents such as antigen-antibody complexes 
(21) or hapten-gelatin (22), which not only blockade adult B cells but actually 
prevent fully differentiated antibody-forming cells from making a  plaque,  a 
phenomenon  we termed "effector cell blockade" (23). It remains to be determined 
what the relationships among all these different forms of B-cell suppression 
really are (cf. reference 27). 
Data obtained with spleen cells from mice suppressed for the 8-allotype (see 
3 Nossal,  G.  J.  V.,  and B.  Pike.  1977.  Further evidence for the clonal selection theory of B 
lymphocyte stimulation. Manuscript submitted for publication. 1480  IgD AND  TOLERANCE 
footnote 2),  by prolonged treatment with anti-8  serum from birth,  are con- 
sistent with our hypothesis that IgD acts in some way as a  failsafe receptor 
against tolerance. Interestingly, some spleen  cells from suppressed  mice can 
reexpress IgD after 24- to 48-h culture in vitro (see fn. 2). These results, as well 
as the anti-8  pretreatment experiments, indicate that IgDobearing cells are 
indeed susceptible to in vitro tolerance induction if exposed to tolerogen before 
their ~-receptor is resynthesized.  We are presently investigating whether spleen 
cells from 8-suppressed mice lose their susceptibility to tolerogenesis al~er 24-48 
h in vitro. 
We have also noted that the frequency of anti-FLU precursors in suppressed 
spleen cells exposed to  FLU-HGG  (i.e.  tolerized) is greatly reduced by this 
process  (Table  II).  A  similar  tolerance  susceptibility,  in  terms  of clonable 
precursors, was observed with spleen cells from male CBA/N mice (N. Klinman, 
personal communication), which seem to have a paucity of surface IgD recep- 
tors,  among other defects. Thus,  we  are  inducing the  adult counterpart of 
"clonal abortion" (3, 4) by manipulation of the 8-receptor in vivo or in vitro. 
How do these results relate to the relatively late appearance of IgD in B- 
lymphocyte ontogeny (16)? That is,  resistance to tolerance may appear even 
though the majority of B cells are in fact/~-only cells (1, 3). Firstly, our results 
and those of Klinman and his colleagues (1) argue against the notion that IgM 
acts solely as a tolerogenic receptor, as originally postulated (7). Most probably, 
some  p-only  cells  appearing  early  in  ontogeny  can  discriminate  between 
tolerogenic and immunogenic signals and are stimnlatable.  If this were not 
true, we would not be able to engender a "positive control" response in neonatal 
spleen cultures in which IgD-bearing cells are rare or absent.  Furthermore, 
spleen cells from mice 2 wk of age are quite resistant to tolerogenesis by FLU 
hapten conjugates although about half of their splenic B cells are still p-only. 
It is worth pointing out that measurement of the percentage of IgM-vs.  IgD- 
bearing cells at a given time reflects the total B-cell repertoire of specificities, 
which Klinman and co-workers (24, 25) have shown to appear in a programmed 
fashion. That is, 2-4-dinitrophenyl (DNP) precursors appear before FLU precur- 
sors, which antedate phosphorylcholine(Pc)-specific precursors. Moreover, ac- 
quisition  of resistance  to  tolerance  induction  follows  the  same  sequential 
pattern of diversification. Hence, it is possible that DNP precursors become 
IgD positive at an earlier time than Pc-specific  B cells. Thus, it one were to 
isolate FLU precursors from 7-day-old mice (which are susceptible to tolerance 
induction), one might predict that these FLU-specific cells would be mostly 
IgM only cells. FLU precursors from 2- to 3-wk-old mice resistant to toleroge- 
nesis would be predicted to be IgM-IgD doubles (p  +  8-cells)  although on a 
total B-cell basis, most cells would still be IgM only (~-only cells).  Hence the 
dynamic maturation is a programmed sequence which is clonotype-specific as 
well as  isotype-related. We  are  currently testing this  hypothesis with cells 
isolated off FLU-gelatin dishes (22). 
An alternative, but not mutually exclusive hypothesis, is that the  p-only 
cells in the spleens of older mice are T-I B cells, as previously suggested (6-8). 
These cells might normally be rendered unresponsive in vitro but their tolerant 
state would not be  detectable in  our thymus filler readout system.  Formal D.  W.  SCOTT,  J.  E.  LAYTON,  AND  G.  J.  V.  NOSSAL  1481 
proof of the susceptibility of ~t-only cells to tolerogenesis is currently under 
investigation with antihapten affinity columns (26)  4 to separate p-only from ft 
+ g-cells. 
Finally, it is interesting to consider that cells which have differentiated to 
express a new surface isetype (IgD) and are also resistant to tolerance induction 
may revert back to a  "less differentiated" behavior by the simple removal or 
blockade of their IgD receptor. Thus the/~ + 8-cell behaves phenotypically like 
a  neonatal  ~-only B  cell under these circumstances. This suggests that the 
appearance of IgD simply represents the acquisition of an additional level of 
control,  which is  a  reversible event.  How the g-receptor acts  as  a  failsafe 
receptor and  the  nature  of the  negative  signals  which the  ~-receptor can 
provide are totally unknown. The model presented in this paper, using anti~ 
and allotype-congenic  mice, should provide some answers to these questions. 
Summary 
Adult spleen cells from C57BL.Ig  ~ mice, which generally are resistant to in 
vitro tolerance induction in the B-cell  compartment, became hyporesponsive 
(tolerant)  when  cultured with  antigen  in  the  presence of an  anti-allotype 
serum. Both antigen and anti~  had to be present for this effect, which was 
hapten-specific and  did  not  occur  in  C57BL/6 mice,  which  lack  the  Ig5-1 
allotype of the 8-chain detected in this system. Preculture with anti-re serum 
plus antigen, in contrast, did not cause tolerance induction in adult spleen B 
cells of either strain. These results suggest that the surface IgD may act as a 
failsafe receptor to  prevent tolerance induction in  adult  B  cells.  Tolerance 
studies with spleen cells from mice with markedly reduced numbers of IgD  +~e 
cells, because of a regimen of repeated injections of anti~ serum beginning at 
birth  (8-suppressed  mice),  confirmed the  importance of membrane  IgD  in 
preventing tolerance, because such 8-suppressed mice were hypersusceptible to 
tolerance by antigen alone. Inasmuch as immature B cells lack IgD on their 
surface, these studies suggest that acquisition of IgD is an important matura- 
tional  step  in  the  ability of murine B  cells to  discriminate tolerogenic and 
immunogenic signals. 
Note Added in Proof." Recently, Vitetta et al., have also found that a heterologous anti~, but 
not an anti-~, will facilitate tolerance induction in adult T-D B cells in vitro (J. Exp. Med.  146: 
1804). Their results confirm our basic findings. 
We thank Dr. James Goding for anti~ serum, and Miss E. Cain for technical assistance. 
Received for publication 3 August 1977. 
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